title: Can molecular diagnostics usher in a new era for screening, diagnosis, and treatment of ovarian cancer?
authors.affiliation: Dr. Mutch is the Judith and Ira Gall Professor in the Department of Obstetrics and Gynecology at the Washington University School of Medicine, St. Louis, Missouri; e-mail: mutchd@wudosis.wustl.edu.
authors.forename: David G
authors.initials: DG
authors.lastname: Mutch
mesh_terms: D014408:Biomarkers, Tumor / Q000032:analysis*; D018284:Cystadenocarcinoma, Serous / Q000175:diagnosis*; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000175:diagnosis*; D016159:Tumor Suppressor Protein p53 / Q000032:analysis*
chemical_list: D014408:Biomarkers, Tumor; C495901:TP53 protein, human; D016159:Tumor Suppressor Protein p53